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Dynamic gene expression during cellular differentiation is tightly coordinated by transcriptional and post-
transcriptional mechanisms. An emerging theme is the central role of long noncoding RNAs (lncRNAs) in
the regulation of this specificity. Recent advances demonstrate that lncRNAs are expressed in a lineage-spe-
cific manner and control the development of several cell types in the hematopoietic system. Moreover, spe-
cific lncRNAs are induced to modulate innate and adaptive immune responses. lncRNAs can function via
RNA-DNA, RNA-RNA, and RNA-protein target interactions. As a result, they affect several stages of gene
regulation, including chromatinmodification,mRNAbiogenesis, and protein signaling.We discuss recent ad-
vances, future prospects, and challenges in understanding the roles of lncRNAs in immunity and immune-
mediated diseases.Introduction
The development and activation of functionally specialized
hematopoietic lineages is precisely regulated to generate
robust immunity while limiting autoimmunity. Efforts over the
past several decades have focused on clarifying cellular mech-
anisms of the immune response and have been driven by
pioneering techniques for cellular analysis, including flow
cytometry and fluorescence imaging (Lanier et al., 1983; Miller
et al., 2002). As a result, our current understanding of the
stages of hematopoiesis, cellular interactions during the im-
mune response, and cell-type-specific immune functions are
well developed. Parallel advances in DNA and protein engineer-
ing have defined protein functions underlying these cellular be-
haviors, particularly for DNA-binding transcription factors and
chromatin-modifying complexes (Capecchi, 1989; Yui and
Rothenberg, 2014). However, our understanding of the immune
functions of non-protein-coding regulatory RNAs (ncRNAs) is
comparatively lacking.
The concept that ncRNAs can have a central role in biological
processes has been recognized for many years; for example,
rRNAs and tRNAs are required for protein synthesis (Lafontaine,
2015; Raina and Ibba, 2014), and small nuclear RNAs (snRNAs)
and small nucleolar RNAs (snoRNAs) are required for mRNA
splicing and nuclear organization (Karijolich and Yu, 2010). How-
ever, recent advances in genome sequencing and microarray
technology have revealed that ncRNA transcription might be
more prevalent than previously appreciated (Kapranov et al.,
2002; Rinn et al., 2003). Greater than 70% of the genome is tran-
scribed, and the majority of transcribed elements generate
ncRNA (Djebali et al., 2012). As a result of these studies, the
catalog of annotated and functionally analyzed ncRNAs has
rapidly expanded, particularly for miRNAs, a family of small
RNAs that primarily act via induction of mRNA degradation or
inhibition of mRNA translation (Bartel, 2009).
The functions of long ncRNAs (lncRNAs) are only now starting
to be understood. Central roles for lncRNAs have been uncov-
ered in a diverse set of biological processes, including genomic
imprinting (H19 and Air), X chromosome inactivation (Xist),
stem cell differentiation (lincRNA-RoR), and cancer metastasis792 Immunity 42, May 19, 2015 ª2015 Elsevier Inc.(HOTAIR), among many others (Flynn and Chang, 2014; Lee
and Bartolomei, 2013; Tsai et al., 2011). Surprisingly, lncRNAs
do not appear to have a single archetype but rather act through
a variety of mechanisms, ranging from chromatin modification to
cell signaling (Wang and Chang, 2011). Indeed, how lncRNAs act
has become as important a question as where they act and has
progressed the study of these molecules to systems where
extensive groundwork has been laid for the examination of their
molecular interactions.
One example of this progression is the rapidly expanding body
of work on lncRNAs in the immune system. Studying lncRNAs
within the context of the immune response has unique advan-
tages: (1) the cellular stages of development for each lineage
are finely mapped, as are the protein regulatory networks under-
lying their commitment; and (2) human and mouse cell counter-
parts are easily identified, accessible, and modified ex vivo.
Therefore, not only will studies on immune lncRNAs most likely
identify new molecular players in immune processes, but they
might also provide novel insights into general governing princi-
ples of lncRNA biology. In this review, we focus on recent
advances in lncRNAs in the context of the immune response.
Our goal is to highlight their cell-type specificity, diversity of
interactions, and pervasiveness in multiple stages of immune
system development and function.
Genome Regulation by lncRNAs
ncRNAs are broadly classified into either short ncRNAs or
lncRNAs on the basis of a cutoff length of 200 nt, primarily for dis-
tinguishing lncRNAs from the functionally distinct small RNA
classes, such as miRNAs. There are at least 10,000 human
lncRNAs, and some estimates suggest that up to 60,000
lncRNA genes (more than twice the number of protein-coding
genes) are transcribed across all cell types (Derrien et al.,
2012; Harrow et al., 2012; Iyer et al., 2015). The majority of
lncRNAs are transcribed, capped, spliced, and polyadenylated
similarly tomRNAs (Guttman et al., 2009). Presently, these genes
are further subcategorized—namely, as long intergenic ncRNAs
(lincRNAs), intronic lncRNAs, and antisense lncRNAs—accord-
ing to their position relative to protein-coding mRNAs (Mattick
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fications primarily provide positional rather than functional
information, given that lncRNAs from different subclasses can
have overlapping mechanisms of action. Another large class of
lncRNAs is composed of enhancer RNAs (eRNAs), which are
transcribed bidirectionally from active enhancer elements (Rinn
and Chang, 2012). eRNAs are capped but not spliced or polya-
denylated. Some eRNAs participate in the transcriptional activa-
tion of target genes, but functions for the vast majority of these
molecules are not known.
Like translated proteins, lncRNAs have modular domains
that can bind proteins through secondary or higher-order RNA
structures; they can also bind nucleic acid sequences via base
pairing (Cruz and Westhof, 2009; Guttman and Rinn, 2012). As
a result, lncRNAs can act biochemically through RNA-protein,
RNA-DNA, or RNA-RNA interactions. In addition, the act of
lncRNA transcription itself can generate changes in chromatin
accessibility or protein binding independently of its gene product
(Latos et al., 2012; Petruk et al., 2006). The implication of such
complex interactions is two-fold. First, depending on their cyto-
plasmic or nuclear location, lncRNAs can affect gene regulation
by modifying different stages of target mRNA transcription or
protein function. Second, lncRNA interactomes can be exam-
ined via protein-centric, DNA-centric, or RNA-centric molecular
methods (Chu et al., 2015a). Therefore, the study of lncRNAs
has motivated the generation of novel analysis techniques,
which will be discussed further throughout this review.
Conceptually, it is useful to discuss lncRNA function accord-
ing to target interactions with protein, RNA, or DNA elements.
A major protein partner of lncRNAs is the family of chromatin
modifiers that regulate accessibility of DNA via chemical mod-
ifications of histones (Peschansky and Wahlestedt, 2014). For
example, the lncRNA Xist binds several chromatin-modification
enzymes, including polycomb repressive complex 2 (PRC2),
to place repressive histone modifications locally on the inactive
X chromosome (Xi) (Chu et al., 2015b; Wutz, 2011). Similarly,
the lncRNA HOTTIP can bind WDR5 (WD-repeat-containing
protein 5), a key component of the MLL-Trx (mixed lineage leu-
kemia-trithorax) complex, to catalyze activating H3K4me3
marks and maintain gene activation in the HOXA locus (Wang
et al., 2011). Additional protein partners include ribonucleopro-
teins (RNPs), which directly regulate transcription (Dimitrova
et al., 2014; Huarte et al., 2010), and cytoplasmic signaling
proteins, the actions of which can be modified by decoy or
scaffolding functions of lncRNAs (Kino et al., 2010; Rapicavoli
et al., 2013). lncRNA-RNA interactions are less understood
but appear to target mRNA stability and translation. For
example, the antisense lncRNA transcribed from the Uchl1
locus regulates Uchl1 translation under stress conditions (Car-
rieri et al., 2012).
Importantly, a single lncRNA can contain several modular do-
mains that bind either proteins or nucleic acid sequences (Gutt-
man and Rinn, 2012; Tsai et al., 2010). As a result, lncRNAs are
able to coordinate input and output signals between different
types of macromolecules. For example, HOTTIP transmits
spatial information within the nucleus by linking multiple HOXA
genes (via DNA-binding modules) together with WDR5 (via a
protein-binding module) through chromosomal looping (Wang
et al., 2011). Similarly, Xist requires the presence of a secondprotein-interaction module (repeat C region) that binds the tran-
scription factor YY1 in order to target PRC2 to the Xi (Jeon and
Lee, 2011). The mechanisms by which lncRNAs physically target
these complexes to genomic elements include traditional duplex
DNA-RNA base pairing (Lee, 2009) and the formation of more
complicated triplex structures (Schmitz et al., 2010). Finally,
recent studies also suggest that some annotated lncRNAs can
be translated and function as short peptide fragments rather
than strictly as RNA molecules, adding to the diversity of
possible intracellular interactions (Anderson et al., 2015).
Molecular Specificity from Combinatorial Inputs
The expression of many lncRNAs is highly cell-type specific,
perhaps even more so than that of lineage-determining proteins,
such as transcription factors (Cabili et al., 2011; Guttman et al.,
2010; Washietl et al., 2014). This specificity appears to be tightly
regulated given that expression patterns and lncRNA promoter
sequences are conserved across evolutionary time (Washietl
et al., 2014). In contrast, the sequence conservation of these
genes between species is significantly less than that of pro-
tein-coding genes (Guttman et al., 2009, 2010; Ponjavic et al.,
2007). These observations suggest that lncRNAs are rapidly
evolving and are evolutionarily testable elements that provide
additional mechanisms of regulatory control necessary for the
emergence of higher organisms (Mattick, 1994). In the context
of cellular differentiation, it is possible that this added layer of
complexity might have evolved to establish lineage-specific
gene-expression activity from combinatorial transcription factor
inputs (Mattick et al., 2010; Stergachis et al., 2014) (Figure 1). For
example, lncRNAs might function as RNA intermediates be-
tween cell-extrinsic signals and the assembly of distinct regula-
tory complexes on cell-type-specific (and species-specific) DNA
elements.
Several studies have demonstrated a crucial role for specif-
ically expressed lncRNAs in the differentiation of cell lineages.
HOTAIR is expressed in posterior and distal skin fibroblasts
and regulates HOX patterning required for the maintenance of
their positional identity (Li et al., 2013; Rinn et al., 2007). Another
skin-specific lncRNA is TINCR, which is induced during differen-
tiation of the keratinocyte lineage; knockdown of TINCR results
in failure to upregulate key protein mediators of epidermal barrier
formation (Kretz et al., 2013). A search for differentially ex-
pressed genes in early mouse embryogenesis identified the
posterior-mesoderm-specific lncRNA Fendrr (Grote et al.,
2013). Deletion or knockdown of Fendrr results in malformations
of mesoderm-derived organs, including the heart and body
wall (Grote et al., 2013; Sauvageau et al., 2013). A similar role
for the lncRNA Braveheart in cardiac lineage specification has
also been reported (Klattenhoff et al., 2013). Finally, a large-scale
analysis of lncRNA function in embryonic stem cells (ESCs)
revealed significant roles for several lncRNAs in themaintenance
of pluripotency (Guttman et al., 2011). Individual ESC lncRNAs
physically interact with distinct classes of chromatin regulators
to epigenetically repress differentiation toward terminal cell
lineages.
lncRNAs in Normal and Neoplastic Hematopoiesis
Hematopoietic stem cells (HSCs) drive hematopoiesis through
continuous self-renewal and differentiation (Bryder et al.,Immunity 42, May 19, 2015 ª2015 Elsevier Inc. 793
Figure 1. Lineage-Specific Functions of lncRNAs
(A) Selectively expressed lncRNAs can regulate cell-fate decisions in the hematopoietic system; for example, lncRNAs can affect the differentiation of macro-
phage (blue) and dendritic cell (DC; green) lineages from a common myeloid progenitor (Carpenter et al., 2013; Wang et al., 2014). lncRNAs can also regulate the
activation state of cell types, for example, by inducing distinct cytokine expression profiles in activated macrophages (pink) and DCs (orange) after pathogen
recognition (Carpenter et al., 2013; Guttman et al., 2009).
(B) Lineage-specific lncRNA expression (1–3) can be induced by combinatorial transcription factor inputs (TF1–TF3) downstream of different signaling pathways
(colored arrows). Transcription factors bind to DNA enhancer elements and activate expression of specific lncRNAs through interactions with Mediator and
RNA polymerase II transcriptional complexes (light-pink circles on the left). lncRNAs modulate immune differentiation and activation through a variety of
biochemical mechanisms, including chromatin modification, protein scaffolding, and direct mRNA interaction (right) (Wang and Chang, 2011). lncRNAs
can recruit chromatin-modifying proteins to target gene loci by directly binding DNA elements or by bridging interactions between chromatin regulators and
DNA-binding proteins (top right). Additional lncRNA-protein modules include decoy functions in signaling pathways, scaffolding of regulatory protein complexes,
and allosteric modulation of protein function (middle right). Finally, base pairing of lncRNAs with target mRNAs can lead to decreased mRNA stability and/or
translational efficiency (bottom right).
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wise restriction of alternative fate choices, and these decisions
are maintained by epigenetic programs (Yui and Rothenberg,
2014). Recent advances in understanding lncRNA-chromatin
interactions, particularly in ESCs, suggest that lncRNAs might
also play a role in the regulation of HSC maintenance and
differentiation.
H19 Regulates Early Hematopoiesis
Two important questions are whether lncRNAs that regulate
global functions, such as genomic imprinting and X chromosome
inactivation (XCI), continue to perform these functions in immune
cells and whether these functions are necessary in this setting.
The lncRNA H19, which has been shown to regulate maternal
imprinting during embryogenesis, binds to methyl-CpG-bind-
ing-domain protein 1 (MBD1) and recruits histone-lysine-methyl-
transferase-containing complexes to place repressive H3K9
methylation marks on target imprinted loci (Leighton et al.,
1995; Monnier et al., 2013). H19 is highly expressed in long-
term HSCs (LT-HSCs) and progressively downregulated (from
the maternal allele) as LT-HSCs differentiate into short-term
HSCs (ST-HSCs) and multipotent progenitors (Venkatraman
et al., 2013). Hematopoietic deficiency of maternal H19 expres-
sion in vivo results in a decrease in LT-HSCs and a concomitant
increase in ST-HSCs. This effect is secondary to impaired HSC794 Immunity 42, May 19, 2015 ª2015 Elsevier Inc.quiescence; H19-deficient HSCs more readily enter the cell
cycle, resulting in increased proliferation and decreased long-
term self-renewal. Importantly, this phenotype is at least partially
mediated by de-repression of maternal Igf2, the target of H19
during embryogenesis. In addition, H19 functions as a precursor
of themiRNAmiR-675,which inhibits translationof the IGF2-IGF1
receptor (IGF1R) (Venkatraman et al., 2013). As a result of H19
deficiency, signaling through IGF1R is increased, leading to a
loss of downstream FOXO3-dependent inhibition of cell-cycle
entry. Taken together, these data establish a role for the mater-
nally imprinted lncRNA H19 in the regulation of HSC function.
Recent findings suggest that two additional lncRNAs, lncHSC-1
and lncHSC-2, also control self-renewal and early lineage deci-
sions in HSCs by regulating chromatin states (Luo et al., 2015).
Long Noncoding Tumor Suppressors and Oncogenes
Do lncRNAs function to suppress leukemogenesis? This ques-
tion was examined in the context of Xist and XCI (Yildirim
et al., 2013). X chromosome dosage compensation had previ-
ously been associated with several malignancies; however, a
causal role had not been established (Pageau et al., 2007). The
study by Yildirim and colleagues demonstrated that conditional
deletion of Xist in hematopoietic cells of female mice results in
the development of massive lymphoid organomegaly, lymphoid
infiltration of end organs, and lethal myeloid leukemia. Also
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multilineage dysplasia, recapitulating the phenotypic evolution
seen in human myelodysplastic/myeloproliferative (MDS/MPN)
overlap syndromes (Vainchenker et al., 2011). The dramatic
cancer phenotype in these mice maps to a cell-autonomous
defect in HSCs (Yildirim et al., 2013). Xist-deficient HSCs display
aberrant markers of maturation and self-renewal, and transplan-
tation of these cells into wild-type recipients results in transfer
of disease, whereas the reciprocal experiment does not. Mech-
anistically, Xist deficiency in HSCs leads to progressive Xi reac-
tivation (a new concept), which most likely mediates malignant
transformation through de-repression of X chromosome genes
and additional X-autosome interactions. Microarray analysis of
purified HSCs and differentiated cell populations revealed the
dysregulation of several factors previously associated with the
development of myeloid leukemia, including Gata1, Flt3, Myb,
and Csf1. Broadly, the affected genes in Xist-deficient cells
encompass defects in DNA replication, genome stability, and
key developmental transcription factor pathways. These targets
serve as starting points for future studies aimed at defining the
molecular basis for MDS/MPN overlap syndromes.
A role has also been discovered for lncRNAs in the growth of
leukemic cells after transformation (Trimarchi et al., 2014). Tri-
marchi and colleagues generated comprehensive transcriptome
profiles of human T cell acute lymphoblastic leukemia (T-ALL)
samples and identified the expression of more than 1,000 novel
lncRNAs, the majority of which are highly specific to the T cell
lineage. Moreover, many of those lncRNAs are uniquely ex-
pressed in T-ALL cells (rather than in untransformed T cells),
demonstrating the dynamic nature of the lncRNA landscape after
transformation. One such lncRNA, LUNAR1 (leukemia-induced
noncoding activator RNA), is highly expressed in T-ALL cells,
and its expression is dependent on signaling through the
oncogenic NOTCH1 receptor. Strikingly, LUNAR1 depletion in
T-ALL cells decreases the number of actively cycling cells and
confers a competitive growth disadvantage upon in vivo transfer
in a xenograft model.
Analysis of higher-order chromatin architecture in T-ALL cells
by genome-wide chromosome conformation capture (Hi-C)
(Lieberman-Aiden et al., 2009) revealed the close nuclear asso-
ciation between LUNAR1 and its neighboring locus IGF1R
(Trimarchi et al., 2014). IGF1R has been implicated in T-ALL as
a receptor critically required for tumor growth (Medyouf et al.,
2011). The association with LUNAR1 is functional, given that
knockdown of that lncRNA also decreases expression of
IGF1R, and gene-expression analysis after LUNAR1 knockdown
showed that it controls a large group of genes also affected by
pharmacologic inhibition of IGF1R. Moreover, ectopic expres-
sion of IGF1R in T-ALL cells lacking LUNAR1 rescues the
growth-defect phenotype, confirming IGF1R as a key LUNAR1
target. In summary, the studies on Xist and LUNAR1 identify
roles for lncRNAs in controlling leukemogenesis. They also high-
light the power of analyzing lncRNA function within the acces-
sible hematopoietic system, which allows for high-resolution
cellular mapping and ex vivo manipulation of target cells. Finally,
the striking specificity of LUNAR1 expression in T-ALL cells
suggests that it (and lncRNAs in general) can also be useful as
markers for distinguishing cell lineages in vivo, particularly for
the classification of cancer subtypes (Brunner et al., 2012).lncRNAs in Erythro-megakaryocytic Development
The lineage specificity of lncRNAs has been coupled with ‘‘guilt-
by-association’’ analysis (Guttman et al., 2009) for the identifica-
tion of novel regulators of hematopoietic differentiation (Figure 2).
One study has used this approach to examine erythroid lineage
differentiation in mice (Hu et al., 2011). Next-generation RNA
sequencing (RNA-seq) analysis of erythroid progenitor stages
downstream of the HSC identified more than 200 dynamically
regulated lncRNAs. lincRNA-EPS (erythroid prosurvival) is the
most highly induced lncRNA during this cellular progression
and is specifically upregulated between the stages of Ter119
CFU-E progenitors and Ter119+ terminally differentiated erythro-
blasts. Moreover, lincRNA-EPS is not expressed in several other
hematopoietic lineages, suggesting that it might be involved in
terminal differentiation and/or survival of end-stage erythro-
cytes. Indeed, small hairpin RNA (shRNA)-mediated depletion
of lincRNA-EPS in erythrocytes results in proliferation arrest
and apoptosis, and conversely, overexpression of the transcript
promotes erythrocyte survival even in the absence of growth
factor signaling. Microarray profiling following ectopic expres-
sion of lincRNA-EPS showed the downregulation of several
critical genes involved in apoptosis; among them were Cideb
and Pycard, two pro-apoptotic activators of the caspase
cascade (Ohtsuka et al., 2004).
Subsequent studies performed in-depth analyses of erythro-
cyte and megakaryocyte lineage differentiation by combining
gene-expression profiling with surveys of chromatin state
and transcription factor occupancy (Alvarez-Dominguez et al.,
2014; Paralkar et al., 2014). This approach also identified the
induction of several hundred lncRNAs during differentiation,
the majority of which are regulated by the lineage-specifying
transcription factors GATA1, TAL1, and KLF1. One such lncRNA,
alncRNA-EC7, is transcribed from an enhancer neighboring the
gene BAND3. BAND3 is a major anion exchange protein present
on erythrocytemembranes and is implicated in the pathogenesis
of hemolytic anemia (Iwamoto et al., 2001). Knockdown of
alncRNA-EC7 in erythroblasts revealed that it acts in cis to
induce BAND3 expression via long-range chromatin interactions
between the alncRNA-EC7 locus and the proximal region of the
BAND3 promoter (Alvarez-Dominguez et al., 2014). Indeed,
reduction of alncRNA-EC7 expression in erythroblasts ex vivo
leads to impaired maturation and enucleation efficiency. Seven
additional lncRNAs were shown to positively regulate erythro-
cyte maturation when tested via shRNA knockdown (Paralkar
et al., 2014). Six of these genes are not expressed in human
cell counterparts, and in total, only 15% of erythroid lncRNAs
identified in mice are also expressed in humans, providing addi-
tional evidence of the striking species specificity of lncRNAs in
addition to their lineage restriction.
lnc-DC and HOTAIRM1 in Myeloid Differentiation
Hematopoietic lineages are broadly derived either from common
lymphoid progenitors or from common myeloid progenitors
downstream of the HSC. Although the strict distinction of cell
types intomyeloid and lymphoid branchesmight not be accurate
(Naik et al., 2013), it provides a useful cellular framework for
studying themolecular control of their differentiation. HOTAIRM1
(HOXA transcript antisense RNA, myeloid-specific 1) was the
first lncRNA suggested to play a role in the differentiation of
myeloid cells (Zhang et al., 2009). HOTAIRM1 is encoded withinImmunity 42, May 19, 2015 ª2015 Elsevier Inc. 795
Figure 2. lncRNAs Regulate Hematopoiesis and Immune Activation
LncRNAs that regulate immune system development and activation are shown next to the cellular stage at which they act (left panel). For several lncRNAs,
their proposed mechanism of action and key target genes are shown (right panels). H19 and lnc-DC are examples of lncRNAs that control hematopoietic
differentiation. H19 maintains long-term HSC quiescence and self-renewal (Venkatraman et al., 2013). H19 binds MBD1 (methyl-CpG-binding domain protein 1)
and recruits methyltransferase complexes to place repressive methylation marks (red circles) on target imprinted loci (Monnier et al., 2013). lnc-DC controls DC
differentiation by promoting phosphorylation and nuclear translocation of a key DC transcription factor, STAT3 (signal transducer and activator of transcription 3)
(Wang et al., 2014). lnc-DC binds to STAT3 and inhibits its interaction with the tyrosine phosphatase SHP1 (Src homology region 2 domain-containing phos-
phatase 1). NRON (non-protein-coding RNA, repressor of NFAT) and NeST (Nettoie Salmonella pas Theiler’s) are examples of lncRNAs that regulate adaptive
immune responses. NRON restricts inappropriate activation of CD4+ T cells by sequestering phosphorylated NFAT (nuclear factor of activated T cells) in the
cytoplasm in a large protein complex with IQGAP (IQ-motif-containing GTPase-activating protein 1) and LRRK2 (leucine-rich repeat kinase 2) (Willingham et al.,
2005). Upon T cell activation, NFAT is dephosphorylated and enters the nucleus, where it can activate gene transcription. NeST is required for Ifng expression in
CD8+ T cells and CD4+ T helper 1 (Th1) cells (Collier et al., 2012; Gomez et al., 2013). NeST binds WDR5 (WD-repeat-containing protein 5), the core subunit of the
MLL (mixed lineage leukemia) methyltransferase complex, and recruits it to the Ifng locus, where it catalyzes H3K4 methylation (blue diamonds) and activates
transcription. Finally, Lethe and lincRNA-Cox2 act in the innate immune response to regulate inflammatory gene transcription. Lethe is induced by IL-1b and
TNF-a and acts as a NF-kB decoy molecule to limit inflammation (Rapicavoli et al., 2013). Lethe binds nuclear RelA homodimers and prevents their accumulation
at target gene loci, including Il6. lincRNA-Cox2 is induced downstream of TLR activation in macrophages and DCs to repress and activate large gene sets
(Carpenter et al., 2013). lincRNA-Cox2-dependent gene repression is mediated by its association with the heterogeneous nuclear RNA-binding proteins hnRNP-
A/B and hnRNP-A2/B1.
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during terminal differentiation of granulocytes from myeloid pro-
genitors. Knockdown of HOTAIRM1 in an acute promyelocytic
leukemia cell line results in inhibition ofHOXA1 andHOXA4 tran-
scription and a decrease in the expression of genes associated
with granulocyte activation, defense response, and maturation
(Zhang et al., 2014).796 Immunity 42, May 19, 2015 ª2015 Elsevier Inc.lncRNAs have been studied in greater depth in the context of
dendritic cell (DC) differentiation. RNA-seq and chromatin-
accessibility analysis of differentiating myeloid DC progenitors
identified the lncRNA lnc-DC to be highly upregulated during dif-
ferentiation by the transcription factor PU.1 (Wang et al., 2014).
lnc-DC is selectively expressed in classical antigen-presenting
DCs (cDCs), but not in plasmacytoid DCs, monocytes, or other
Immunity
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or of its murine ortholog in vivo results in impaired differentiation
and decreased expression of several factors necessary for cDC
function. These include proteins involved in T cell activation
(CD40, CD80, and CD86), antigen presentation (HLA-DR), and
cytokine secretion (interleukin-12 [IL-12]). In fact, gene-expres-
sion analysis following lnc-DC knockdown in humans revealed
a decrease in the expression of more than 600 coding genes.
Functionally, lnc-DC-deficient cDCs are impaired in their ability
to internalize exogenous antigens and stimulate allogeneic
CD4+ T cells.
How does lnc-DC act to control such broad cDC functionality?
Wang and colleagues performed a pull-down assay of in-vitro-
transcribed biotinylated lnc-DC and subsequent mass spec-
trometry to identify potential interacting protein partners (Wang
et al., 2014). This approach revealed a novel interaction between
lnc-DC and signal transducer and activator of transcription 3
(STAT3), an interaction confirmed by RNA immunoprecipitation
(RIP). STAT3 is a transcription factor required for DC differentia-
tion and acts downstream of key DC growth factor receptors
(Laouar et al., 2003). Binding of lnc-DC to the C terminus of
STAT3 leads to maintenance of phosphorylation of the protein
at tyrosine 705 (Y705), which is critical for its nuclear transloca-
tion. By contrast, lnc-DC deficiency results in an association
between STAT3 and the protein tyrosine phosphatase SHP1,
decreased Y705 phosphorylation, and subsequent cytoplasmic
sequestration. Comparison of lnc-DC- and STAT3-dependent
transcripts confirms an overlap in downstream gene targets.
In summary, the findings of these studies strengthen two previ-
ously proposed concepts: (1) that lineage specificity and dy-
namic expression of lncRNAs can suggest their role in biological
processes and (2) that studies of lncRNA function in the immune
system can contribute to the identification of novel mechanisms
of action in vivo.
lncRNAs in the Innate Immune Response
The innate immune system is composed of functionally distinct
myeloid and innate lymphoid lineages, which act in concert to
bridge pathogen sensing and immune activation. DCs are central
to this process and are a particularly attractive cell type to study
because of the relative ease of culturing and activating these
cells in vitro (Satpathy et al., 2012). Guttman and colleagues
took advantage of this system to examine the specificity of
lncRNA expression across tissues and in response to activating
signals (Guttman et al., 2009). Bone-marrow-derived in vitro DCs
(BMDCs) were stimulated with Toll-like receptor 4 (TLR4) ago-
nists and analyzed by RNA-seq. This approach identified 20
signal-specific lncRNAs, 80% of which clustered with NF-kB
signaling components in a systematic analysis of co-regulated
genes across several datasets.
lincRNA-Cox2 and THRIL: Regulators of TLR Signaling
Among the lncRNAs identified by Guttman and colleagues,
lincRNA-Cox2 is induced greater than 1,000-fold after TLR4
activation (Guttman et al., 2009). Subsequently, more detailed
analysis across several cell and stimulation conditions demon-
strated that lincRNA-Cox2 is also upregulated in BMDCs and
bone-marrow-derived macrophages (BMDMs) in response to
activation of TLR1 and TLR2 or TLR7 and TLR8, but not TLR3
(Carpenter et al., 2013). Furthermore, that study showed thattranscription of lincRNA-Cox2 is dependent on signaling through
the TLR adaptor protein MyD88 and the transcription factor
NF-kB. Although these data predict a role for this lncRNA in
gene regulation downstream of NF-kB, knockdown of lincRNA-
Cox2 also has large effects on basal gene expression in the
absence of stimulation by increasing the expression of nearly
800 genes. In TLR2-stimulated BMDMs, lincRNA-Cox2 deple-
tion also leads to gene de-repression and a decrease in the
expression of approximately 700 genes, revealing that it can
act in the same cell to repress and activate large gene sets.
Genes repressed by lincRNA-Cox2 include critical immune-
response regulators, such as the chemokine-encoding genes
Ccl5 and Cx3cl1 and the interferon (IFN)-stimulated genes Irf7,
Oas1a, andOas1l. Genes induced by lincRNA-Cox2 (and depen-
dent on NF-kB) include inflammatory-response genes, such as
Tlr1, Il6, and Il23a.
Although the precise mechanism by which lincRNA-Cox2
affects gene expression is unknown, it could potentially function
through interactions with the RNA-binding proteins hnRNP-A/B
and hnRNP-A2/B1 (Carpenter et al., 2013). hnRNPs are multi-
functional nuclear proteins that have been shown to mediate
lncRNA-dependent gene repression in the context of the p53
response (Huarte et al., 2010). Compared to knockdown of
lincRNA-Cox2, knockdown of Hnrnpab and Hnrnpa2b1 (the
genes encoding hnRNP-A/B and hnRNP-A2/B1, respectively)
in BMDMs results in a similar but not identical dysregulation of
TLR-induced gene expression. Furthermore, superimposing
Hnrnpab or Hnrnpa2b1 silencing on ectopic expression of
lincRNA-Cox2 reverses its repression of Ccl5. These data pro-
vide a mechanism for transcriptional repression by lincRNA-
Cox2 but do not explain its role in gene activation, given that
this set of target genes is not affected by Hnrnpab or Hnrnpa2b1
deficiency. Future studies, perhaps on primary cell types in
lncRNA-Cox2-deficient mice (Sauvageau et al., 2013), will be
useful for dissecting these mechanisms in vivo.
The lncRNA THRIL (TNF- and hnRNPL-related immunoregula-
tory lncRNA) also appears to function through interactions with
an hnRNP factor (Li et al., 2014). Li and colleagues employed a
similar strategy to the approach used for identifying lincRNA-
Cox2 in order to profile lncRNA regulators of the inflammatory
response. An unbiased gene-expression screen in the THP-1
human macrophage cell line identified 159 candidate lncRNA
regulators of the TLR2 response. One of those candidates,
linc1992, was named THRIL because it is essential for basal
and inducible expression of the inflammatory-cytokine-encod-
ing gene TNF (tumor necrosis factor). Transcriptome-wide
analysis of THRIL-depleted THP-1 cells identified more than
300 additional differentially expressed genes downstream of
TLR activation, including IL8, CXCL10, CCL1, and CSF1. THRIL
also regulates the expression of more than 400 genes in steady-
state macrophages, recalling the dual function observed for
lincRNA-Cox2.
Pull-down of protein-coupled THRIL and subsequent mass
spectrometry revealed a specific interaction with the RNA-
binding protein hnRNPL, and knockdown of Hnrnpl (the gene
encoding hnRNPL) also showed a consistent decrease in
TNF-a production by macrophages, suggesting that these two
molecules function as a complex. The authors further deter-
mined whether the THRIL-hnRNPL complex localizes to theImmunity 42, May 19, 2015 ª2015 Elsevier Inc. 797
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chromatin immunoprecipitation of hnRPL enriches for a region
within the TNF promoter in a THRIL-dependent manner. More-
over, chromatin isolation by RNA purification of THRIL, in which
tiled oligonucleotides retrieved the target lncRNA with bound
proteins and DNA sequences (Chu et al., 2011), also demon-
strated an association between the lncRNA and the TNF pro-
moter. All together, these data provide strong evidence of the
specific action of THRIL in recruiting hnRNPL to genomic loci
where it can activate and repress immune-associated gene
transcription.
Lethe and NKILA Restrict NF-kB-Driven Inflammation
The dual functions of lincRNA-Cox2 and THRIL in homeostasis
and activation of inflammatory responses suggest that lncRNAs
might serve as negative regulators of potentially harmful auto-
inflammation. This hypothesis was examined in the context of
the pseudogene lncRNA Lethe, which is highly induced in mouse
embryonic fibroblasts after IL-1b and TNF-a stimulation (Rapica-
voli et al., 2013). Induction of Lethe is critically dependent on
NF-kB activity; however, Lethe deficiency paradoxically results
in the upregulation of NF-kB targets Nfkbia and Nfkb2, suggest-
ing a negative regulatory function. In support of this conclusion,
overexpression of Lethe in the presence of an NF-kB luciferase
reporter leads to a decrease in luciferase activity. RIP analysis
of the NF-kB component p65 (RelA) has shown that Lethe acts
by specifically binding nuclear RelA homodimers and preventing
their accumulation at target genes, including Nfkbia, Il6, and Il8.
Therefore, these results confirm that Lethe acts as a decoy
receptor for NF-kB and provides negative feedback to limit
inflammation in response to TLR activation.
The lncRNA PACER (p50-assocated COX-2 extragenic RNA)
also acts as a decoy molecule in the NF-kB signaling pathway
(Krawczyk and Emerson, 2014). PACER is upregulated after
LPS stimulation in human macrophages and selectively regu-
lates the expression of its neighboring gene PTGS2 (COX-2).
COX-2 (cyclooxygenase 2) is an important enzyme in prosta-
glandin biosynthesis, and it is known to mediate a number of
biological processes, including the inflammatory response
(Smith et al., 2000). After stimulation, PACER binds the NF-kB
p50 subunit and sequesters it away from the PTGS2 promoter,
where p50-p50 homodimers function to repress transcription.
The decrease in free p50 subunits leads to the alternative forma-
tion of activating p50-p65 NF-kB heterodimers and recruitment
of transcription pre-initiation complexes to the PTGS2 locus.
Whether PACER utilizes additional mechanisms to restrict its
effect specifically to PTGS2 remains to be determined. However,
a similar targeted decoy strategy is employed by the lncRNA
Jpx, which upregulates Xist expression by titrating the transcrip-
tional repressor CCCTC-binding factor (CTCF) away from the
Xist promoter at the onset of XCI (Sun et al., 2013).
A recent study suggests that lncRNAs can also act at the post-
translational level to regulate NF-kB signaling (Liu et al., 2015).
Liu and colleagues identified NKILA (NF-kB-interacting lncRNA)
as a highly induced lncRNA in breast cancer cells after IL-1b and
TNF-a stimulation. Similar to knockdown of Lethe, knockdown
of NKILA enhances NF-kB activity, and overexpression of the
lncRNA inhibits NF-kB, revealing its negative regulatory function
in the pathway. Mechanistic analysis has shown that NKILA
forms a stable cytoplasmic complex with NF-kB and IkB (inhib-798 Immunity 42, May 19, 2015 ª2015 Elsevier Inc.itor of NF-kB) and directly masks the phosphorylation motifs of
IkB from IKK (IkB kinase). This association prevents the phos-
phorylation and degradation of IkB and subsequent nuclear
translocation of NF-kB. Together with the function of lnc-DC in
regulating STAT3 phosphorylation, these results identify a novel
lncRNA archetype that functions through post-translational
modification of signaling proteins (Wang and Chang, 2011;
Wang et al., 2014). Further studies are required to determine
whether several lncRNAs can act synergistically in the same
pathway to control the inflammatory state within a single cell.
In summary, genome-wide analyses of ncRNAs regulated by
innate immune activation demonstrate that individual lncRNAs
can be exquisitely specific to particular pathogen-associated
molecular patterns; for example, lincRNA-Cox2 is induced
downstream of specific TLRs (Carpenter et al., 2013), Lethe is
induced downstream of TNF-a and IL-1b signaling (Rapicavoli
et al., 2013), and NRAV (negative regulator of antiviral response)
is downregulated after viral infection (Ouyang et al., 2014).
Therefore, lncRNAs might function as specific internal represen-
tations of external stimuli, even if these stimuli trigger overlap-
ping intracellular signaling pathways (Rapicavoli et al., 2013).
The analysis of Lethe further expands this concept by revealing
that elements such as pseudogenes, largely considered to be
nonfunctional genetic remnants, can be transcribed into func-
tional lncRNAs that might become active only in inflammatory
settings.
Intracellular Signaling by Endogenous Retroviruses
Recent studies suggest that roles for long noncoding genetic
elements in inflammation can also be extended to endogenous
retroviruses (ERVs) (Zeng et al., 2014). T-cell-independent (TI)
antibody responses rely on direct crosslinking of B cell receptors
(BCRs) by TI antigens. Surprisingly, whereas TLRs are dispens-
able for optimal antibody production in this setting, the cytosolic
DNA sensor cGAS (cGMP-AMP synthase) and its downstream
signaling molecule STING (stimulator of interferon genes) are
necessary (Zeng et al., 2014). Furthermore, the signaling adaptor
for intracellular RNA sensors, MAVS (mitochondrial antiviral
signaling protein), is also required. These results suggest that
endogenous nucleic acidsmight stimulate important intracellular
activation pathways after BCR engagement.
Because the cGAS-STING and RIG-I (retinoic-inducible gene
1)-MAVS pathways had previously been implicated in retroviral
sensing (Gao et al., 2013; Solis et al., 2011), Zeng and colleagues
explored the possibility that ERVs activate TI responses in a cell-
autonomous manner (Zeng et al., 2014). Indeed, cytosolic ERV
mRNA and reverse-transcribed cDNA are increased in abun-
dance after B cell stimulation, and ERV-derived nucleic acids
are selectively bound by intracellular sensors and can activate
gene expression. Importantly, depletion of ERV cDNA in vivo
by reverse transcriptase inhibitors leads to impaired TI antibody
production. Two waves of NF-kB signaling are required for this
response. First, NF-kB signaling following BCR engagement is
required for ERV upregulation. Second, ERV activation of intra-
cellular sensors leads to NF-kB-dependent gene-expression
changes. Although further studies of ERVs are needed, these
results indicate that additional classes of genetic elements
previously considered to be ‘‘junk DNA’’ might also encode
functional lncRNA archetypes (Herquel et al., 2013). Moreover,
dysregulation of these genes in disease settings might lead to
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auto-inflammatory responses (Stetson et al., 2008; Tugnet
et al., 2013).
Immune Surveillance of Translated lncRNA Peptides
Ribosome-profiling studies indicate that a small fraction of
lncRNAs can be translated into peptide fragments (Ba´nfai
et al., 2012; Guttman et al., 2013; Ingolia et al., 2011). These pu-
tative peptides are often difficult to detect bymass spectrometry
experiments and are poorly conserved in evolution (Ba´nfai et al.,
2012). Although these findings might reflect the presence of
‘‘translational noise,’’ a few micropeptides might also add func-
tionality separate from that of their RNA precursor. There is
evidence of the latter concept (Anderson et al., 2015), but the
extent to which peptides contribute to overall lncRNA function
is not yet fully understood. Nonetheless, the presence of these
fragments—which can be derived from approximately 8% of
all lncRNA genes (Ba´nfai et al., 2012)—raises the question of
whether they significantly contribute to the antigen repertoire
displayed on the surface of major histocompatibility complex
(MHC) molecules.
A recent study examined this possibility in the context of viral
infection with human cytomegalovirus (HCMV), a double-
stranded DNA virus in the Herpesviridae family (Ingolia et al.,
2014). Previous work had identified novel HCMV open reading
frames (ORFs), many of which do not encode proteins, by ribo-
some profiling of infected human fibroblasts (Stern-Ginossar
et al., 2012). Given that the immune system maintains memory
T cells specific to past infections, challenge with ncRNA-derived
antigens should lead to a rapid recall response if they were
previously immunologically presented. Ingolia and colleagues
tested this hypothesis by using the lncRNA beta 2.7 HCMV,
which contains eight ORFs that generate small peptides. Indeed,
beta 2.7 peptide stimulation of T cells from humans previously
infected with HCMV led to a robust recall response, which was
absent in individuals who had not been infected with the virus
(Ingolia et al., 2014).
Additional lines of evidence further support the presence of
ncRNA-derived peptides on MHC molecules. First, non-canon-
ical translation is upregulated during stress conditions, perhaps
in an effort to identify additional immunogenic antigens (Mell-
man et al., 2011). Second, rapidly degraded micropeptides
bind MHC class I molecules with higher efficiency than stable
protein-coding polypeptides (Yewdell, 2007). All together,
these data suggest the participation of non-protein-coding
peptides, including lncRNA-derived peptides, in active immune
surveillance. Therefore, deeper analysis of these products
might provide insights into the pathogenesis of immune-
regulated diseases, for example, by detecting novel auto- or
neo-antigens.
lncRNAs in the Adaptive Immune Response
Although several lncRNAs regulate innate immune activation
in vitro, none have been tested for function in vivo. Therefore,
the importance of lncRNAs in the context of a systems-level
immune response to pathogens remains somewhat uncertain.
This concern is further supported by previous efforts to identify
functions of lncRNAs, where genetic deletion did not yield
discernable phenotypes in vivo (Ahituv et al., 2007; Nakagawa
et al., 2011; Zhang et al., 2012). Consequently, despite estab-lished roles for classical lncRNAs (Xist and H19), these results
have led to the suggestion that many lncRNAs represent tran-
scriptional noise (Kowalczyk et al., 2012; Struhl, 2007) and that
their function might be overstated by in vitro analysis. However,
recent studies on lncRNAs in the adaptive immune system
have provided some support for their non-redundant function
in pathogen responses in vivo.
NeST Is Required for Pathogen Responses In Vivo
Analysis of mice lacking expression of the lncRNA NeST (Net-
toie Salmonella pas Theiler’s, also known as Tmevpg1) pro-
vided the strongest evidence of an in vivo role of lncRNAs in
the immune response (Gomez et al., 2013). NeST was identified
as an intergenic anti-sense lncRNA located adjacent to Ifng
(Vigneau et al., 2001, 2003). This region had previously been
described as a susceptibility locus for persistence of Theiler’s
virus, a natural mouse pathogen that is cleared after infection
in some mouse strains, but not in others (Brahic et al., 2005).
B10.S and SJL/J mice, which clear the virus and are persis-
tently infected, respectively, were crossed for the generation
of congenic lines so the locus responsible for that susceptibility
phenotype could be narrowed to the region containing NeST,
Ifng, and Il22 (Bihl et al., 1999; Bureau et al., 1993; Levillayer
et al., 2007). Analysis of gene expression in those congenic
lines revealed that NeST expression in T cells was much higher
in mice retaining the SJL-derived locus (Gomez et al., 2013).
Higher NeST expression in those mice correlated with
increased persistence of Theiler’s virus but, interestingly, also
led to resistance to infection by the Gram-negative bacterium
Salmonella enterica (Gomez et al., 2013). Furthermore, trans-
genic expression of the SJL-derived locus conferred resistance
to Salmonella infection and persistence of Theiler’s virus in
B10.S mice.
NeST-dependent phenotypes are due to defects in hemato-
poietic cells (Aubagnac et al., 2002). NeST is expressed in
CD8+ T cells, CD4+ T helper 1 (Th1) cells, and natural killer cells,
and its expression appears to depend on combinatorial actions
of the transcription factors T-bet, STAT4, and NF-kB (Collier
et al., 2012, 2014; Hu et al., 2013). These results, combined
with the proximity of NeST to Ifng, suggest that NeST might
affect pathogen responses through its regulation of the cytokine
IFN-g. Indeed, congenic or transgenic expression of NeST
dramatically increases IFN-g production in activated CD8+
T cells but not in activated CD4+ T cells (Gomez et al., 2013).
Like HOTTIP (Wang et al., 2011), NeST binds WDR5, the core
subunit of the MLL H3K4 methyltransferase complex, and re-
cruits it to Ifng, where it activates transcription. In addition,
NeST also appears to regulate the production of several other
inflammatory proteins, including IL-17, TNF-a, and RANTES,
in CD8+ T cells. Whether the transcription of these genes is
also directed by NeST-mediated epigenetic modifications or
by autocrine IFN-g signaling remains unclear.
lincR-Ccr2-50AS and linc-MAF-4 in T Helper Cells
CD4+ T helper cell subsets are critical for the generation of path-
ogen-specific adaptive immune responses (Murphy and Stock-
inger, 2010). Recent studies have expanded our understanding
of the lncRNA landscape in T cells through the analysis of
detailed gene-expression maps during differentiation (Hu et al.,
2013; Pang et al., 2009; Ranzani et al., 2015). In 42 different
mouse T cell populations, about half of all expressed lncRNAsImmunity 42, May 19, 2015 ª2015 Elsevier Inc. 799
Immunity
Revieware cell-type specific, whereas only 6%–8% of mRNAs show
such specificity (Hu et al., 2013). A similar conclusion can be
made from the analysis of human lymphocyte populations,
even when lncRNA expression is compared across lymphoid
and non-lymphoid tissues (Ranzani et al., 2015). Moreover,
lncRNAs exhibit even higher specificity when only compared
among CD4+ T cell subsets (Ranzani et al., 2015). For example,
deeper analysis of Th1 cell lncRNAs revealed that more
than 90% of these molecules are specific to this lineage and
identified the lncRNA linc-MAF-4, which controls Th1 cell differ-
entiation via epigenetic repression of the Th2 cell transcription
factor MAF.
Analysis of mouse T cell subsets by Hu and colleagues identi-
fied lincR-Ccr2-50AS, a novel lncRNA specific to Th2 cells
(Hu et al., 2013). Knockdown of lincR-Ccr2-50AS does not affect
the development of Th2 cells but does lead to downregulation
of the key Th2 chemokine-encoding genes Ccr1, Ccr2, Ccr3,
and Ccr5. Accordingly, compared to control cells, lincR-Ccr2-
50AS-deficient Th2 cells display an impaired ability to migrate
to the lung upon in vivo transfer. Genome-wide analysis showed
that lincR-Ccr2-50AS modulates the expression of nearly 1,200
genes, which appear to overlap extensively with genes depen-
dent on the ‘‘master’’ Th2 cell transcription factor GATA-3.
Indeed, GATA-3 is required for the expression of lincR-Ccr2-
50AS, and genes co-regulated by both factors are highly enriched
with Th2 cell signature genes. These data suggest that this
lncRNA might function as a second layer of Th2-cell-specific
gene regulation downstream of the actions of a ‘‘master’’ tran-
scription factor.
NRON Regulates Nuclear Translocation of NFAT
Finally, lncRNAs also play a role in restricting inappropriate T cell
responses. Nuclear factor of activated T cells (NFAT) is a
calcium-dependent transcription factor that is critical for T cell
activation (Crabtree and Olson, 2002). An in vitro shRNA screen
identified NRON (non-protein-coding RNA, repressor of NFAT)
as a lncRNA that represses the transcriptional activation of
NFAT-responsive genes (Willingham et al., 2005). Co-immuno-
precipitation and mass spectrometry studies showed that in
resting T cells, NRON forms a large RNA-protein complex that
sequesters phosphorylated NFAT in the cytoplasm (Sharma
et al., 2011; Willingham et al., 2005). Members of the protein
complex include the calmodulin-binding protein IQGAP1 (IQ-
motif-containing GTPase-activating protein 1) and nuclear trans-
port factors such as KPNB1 (karyopherin beta 1). Upon T cell
activation, NFAT is dephosphorylated by the Ca(2+)/calmod-
ulin-dependent phosphatase calcineurin and transported into
the nucleus, where it can activate transcription. Accordingly,
knockdown of NRON results in increased NFAT dephosphoryla-
tion, nuclear translocation, and cytokine production after stimu-
lation (Sharma et al., 2011).
An in vivo function for NRONwas proposed by studies onmice
deficient in leucine-rich repeat kinase 2 (LRRK2), another protein
member of the NRON-NFAT complex (Liu et al., 2011). LRRK2
is physically associated with NRON and IQGAP1 and leads
to their stabilization as a complex with NFAT. As expected,
LRRK2 deficiency also leads to enhanced NFAT nuclear translo-
cation and gene target expression. Importantly, in a model of
autoimmune colitis, Lrrk2/ mice develop more severe disease
than do wild-type controls. Disease manifestations include800 Immunity 42, May 19, 2015 ª2015 Elsevier Inc.greater severity of clinical symptoms, increased infiltration of
the colon by inflammatory cells, and higher levels of inflamma-
tory cytokines. These results, together with the analysis of Lethe
in regulating innate immune activation, suggest that lncRNAs
might play a significant role—still largely unexplored—in
restraining auto-inflammatory damage during the immune
response.
Concluding Remarks
Several conclusions can be made from studies of lncRNAs in
the immune system. First, lncRNA expression is highly cell-
type specific and critical for the development and activation
of immune lineages. Second, lncRNAs have broad functionality,
ranging from the activation of large inflammatory gene sets in
trans to the regulation of single genes in cis. Finally, lncRNAs
contain several modular domains that bridge DNA, RNA, and
protein interactions; as a result, these molecules have the
ability to affect nearly every stage of gene regulation, including
chromatin marks, signaling pathways, and mRNA processing.
The majority of studies to date have focused on TLR activation
in myeloid cells. However, future work will most likely show that
lncRNAs have important functions in other immune processes,
such as coordinating complex gene networks required for
intracellular pathogen recognition, T cell activation, and the
generation of immunological memory, among many others.
Moreover, future studies should naturally extend these roles
to immune-mediated diseases, given that lncRNAs can now
be therapeutically targeted in vivo by antisense oligonucleo-
tides (Meng et al., 2015).
Innovations in flow cytometry and genome engineering have
accelerated our understanding of immunity at the cellular and
protein levels. Now, in the post-genomic era, the use of next-
generation sequencing has led to an explosion of information
regarding the dynamic expression of thousands of lncRNAs in
immune cells, yet functional analysis of these genes has lagged
behind. Moving forward, recent gene-knockout studies have un-
derscored the utility of defining lncRNA functions in the context
of cellular processes in vivo (Bassett et al., 2014; Sauvageau
et al., 2013). This is especially important in the immune system,
where extensive knowledge of cellular differentiation andmolec-
ular networks can inform the relevance of functions identified
in vitro. The development of CRISPR-mediated transcriptional
activation and silencing technologies should aid this effort,
particularly because simple indels introduced by traditional
CRISPR-based gene editing are not likely to disrupt lncRNA
function (Gilbert et al., 2014; Konermann et al., 2015). Further-
more, new methods of defining lncRNA interactomes—their
genomic binding sites, associated proteins, and responsible
RNA domains—will rapidly illuminate mechanisms of lncRNA
action (Chu et al., 2011, 2015b; Quinn et al., 2014). These tools,
combined with the continued improvement of epigenomic
methods for the analysis of rare subpopulations (and even single
cells), will further facilitate the study of lncRNAs in primary
tissues (Buenrostro et al., 2013; Lara-Astiaso et al., 2014).
Ultimately, this integration of genome-level analysis with estab-
lished cellular and molecular techniques will lead to a complete
picture of lncRNA interactions within the cell and, importantly,
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